Why should patients be careful when comparing clinical trial results
Tratamiento personalizado para bajar de peso en Monterrey La inyeccin GLP-1 para bajar de peso en Monterrey , incluyendo el uso de Ozempic , forma parte de un abordaje mdico integral que debe adaptarse a cada persona
In SURMOUNT-1, published in NEJM in 2022, tirzepatide at the 15 mg weekly dose produced a mean placebo-adjusted body weight reduction of 17.8% at 72 weeks in adults with obesity (Jastreboff et al., NEJM, 2022)
Pros and Cons of Using GLP-1 Antagonists When deciding whether to use GLP-1 antagonists, you need to consider both their benefits and potential drawbacks
Additionally, the drug label includes a boxed warning related to a potential risk of thyroid tumors
Emerging studies even suggest potential therapeutic benefits in heart failure, further expanding the clinical utility of this powerful drug class